Dr. Gelfand is a Physician at Massachusetts General Hospital (MGH) and Clinical Professor of Medicine at Harvard Medical School. He also holds an appointment as Professor of Medicine at Tufts University School of Medicine.
For two years he served as Dean for Research at Tufts University School of Medicine and Senior Vice President for Research and Technology at Tufts- New England Medical Center. Dr. Gelfand was Professor and Chairman of the Department of Medicine of Tufts University School of Medicine and Physician-in-Chief at Tufts- New England Medical Center.
Dr.Gelfand has conducted laboratory and clinical research in immunology, inflammation, infection for over 30 years, with more than 90 peer-reviewed scientific publications and 50 chapters in leading textbooks of medicine. Most recently, Dr. Gelfand’s research interests have focused on vaccines for infectious diseases and cancer therapeutics. He founded programs for the Center for Integration of Medicine and Innovative Technology (www.CIMIT.org), which develops solutions to medical problems by fostering collaboration between engineers and physicians. At MGH he co-founded a company to develop methods to enhance immune responses to vaccines, a therapeutic vaccine targeting ovarian cancer, and a vaccine platform to enable rapid and/or personalized vaccines for cancers or infectious diseases.
In 2007, Dr. Gelfand was elected a Fellow of American Association for the Advancement of Science “for distinguished contributions to clinical immunology and vaccine development.”
He has consulted for the US Department of Homeland Security.